Corbus (CRBP) Director Ben Yong Sells 2,000 Shares

What Happened Ben Yong, a director of Corbus Pharmaceuticals Holdings, sold 2,000 shares on September 14, 2026. The filing reports a weighted-average sale price of $7.84 per share for total proceeds of approximately $15,683. This was a sale (not a purchase), and the transaction was effected under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-09-14; Form 4 filed 2026-09-15 (filed the next day, i.e., timely).
• Sale details: 2,000 shares sold; weighted-average price $7.84; reported price range $7.80–$7.90 across multiple trades.
• Plan/authorization: Executed pursuant to a 10b5-1 trading plan adopted by Mr. Yong on June 12, 2026 (Footnote F1).
• Price breakdown: Footnote states the shares were sold in multiple transactions and the filer can provide the number sold at each price on request (Footnote F2).
• Shares owned after transaction: Not explicitly stated here; the filing notes that the reported holdings include 3,800 unvested RSUs subject to vesting schedules (Footnote F3).

Context Sales made under a 10b5-1 plan are pre-planned transactions and are typically routine dispositions rather than real-time signals of the insider’s view. For retail investors, purchases tend to be more informative about insider confidence; this sale should be viewed as part of a pre-authorized plan unless other filings indicate otherwise.